Deals
Abcam Founder Seeks to Oust Chairman of $4 Billion Biotech
- Jonathan Milner wants to name himself as executive chairman
- Abcam says it’s disappointed by Milner’s ‘aggressive tactics’
This article is for subscribers only.
Abcam Plc founder Jonathan Milner said he’s taking steps to call an extraordinary general meeting of shareholders to oust the chairman of the biotech supplier he started 25 years ago.
The British scientist, who was offered a non-executive director position under certain conditions, is now pushing to join the board as executive chairman to replace current chairman Peter Allen, according to a statement Wednesday that confirmed an earlier Bloomberg News report.